EGM
WST icon

Engineers Gate Manager’s West Pharmaceutical WST Stock Holding History

Engineers Gate Manager’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.77M Buy
18,868
+15,653
+487% +$4.79M 0.09% 259
2026
Q1 		$806K Sell
3,215
-8,212
-72% -$2.04M 0.01% 1159
2025
Q4 		$3.14M Buy
11,427
+8,692
+318% +$2.38M 0.04% 503
2025
Q3 		$717K Sell
2,735
-46,113
-94% -$11.2M 0.01% 1330
2025
Q2 		$10.7M Buy
48,848
+47,286
+3,027% +$10.1M 0.13% 207
2025
Q1 		$350K Buy
+1,562
New +$430K 0.01% 1621
2024
Q4 		– Sell
-692
Closed -$208K – 2621
2024
Q3 		$208K Buy
+692
New +$212K ﹤0.01% 1785
2024
Q1 		– Sell
-22,772
Closed -$8.02M – 2347
2023
Q4 		$8.02M Buy
22,772
+21,855
+2,383% +$7.73M 0.23% 92
2023
Q3 		$344K Sell
917
-675
-42% -$261K 0.01% 1252
2023
Q2 		$609K Buy
+1,592
New +$569K 0.02% 945
2022
Q4 		– Sell
-24,578
Closed -$6.05M – 2073
2022
Q3 		$6.05M Buy
24,578
+10,940
+80% +$3.33M 0.38% 34
2022
Q2 		$4.12M Buy
+13,638
New +$4.44M 0.15% 154
2021
Q4 		– Sell
-1,461
Closed -$620K – 2328
2021
Q3 		$620K Buy
1,461
+143
+11% +$60.3K 0.04% 752
2021
Q2 		$473K Buy
1,318
+186
+16% +$61.5K 0.03% 861
2021
Q1 		$319K Buy
1,132
+14
+1% +$4.01K 0.02% 1280
2020
Q4 		$317K Sell
1,118
-19,574
-95% -$5.49M 0.01% 1266
2020
Q3 		$5.69M Buy
20,692
+17,966
+659% +$4.75M 0.27% 52
2020
Q2 		$619K Sell
2,726
-3,181
-54% -$625K 0.03% 841
2020
Q1 		$899K Buy
+5,907
New +$909K 0.06% 481
2019
Q4 		– Sell
-3,684
Closed -$522K – 1864
2019
Q3 		$522K Sell
3,684
-1,680
-31% -$231K 0.03% 760
2019
Q2 		$671K Buy
+5,364
New +$633K 0.04% 622

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Engineers Gate Manager's WST Position: Q2 2026 in Review

Engineers Gate Manager increased its West Pharmaceutical (WST) stake by 487% in Q2 2026, buying an estimated $4.79M and bringing the position to 18,868 shares worth $6.77M. The position accounts for 0.09% of the portfolio, ranked #259.

Engineers Gate Manager first reported a position in WST in Q2 2019 and has held it in 21 quarters since. The position peaked at $10.7M in Q2 2025. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Engineers Gate Manager held 18,868 shares of West Pharmaceutical worth $6.77M as of Q2 2026.
  • Engineers Gate Manager bought 15,653 West Pharmaceutical shares in Q2 2026, an estimated $4.79M.
  • West Pharmaceutical made up 0.09% of Engineers Gate Manager's portfolio in Q2 2026, its #259 holding.
  • Engineers Gate Manager first reported a position in West Pharmaceutical in Q2 2019 and has held it in 21 quarters since.
  • Engineers Gate Manager's West Pharmaceutical position peaked at $10.7M in Q2 2025.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.